Skip to main content
SpringerLink
Log in

Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Barrett AJ, Sloand E (2009) Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance. Haematologica 94(4):449–51. doi:10.3324/haematol.2009.006080

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Giannouli S, Kanellopoulou T, Voulgarelis M (2012) Myelodysplasia and autoimmunity. Curr Opin Rheumatol 24(1):97–102. doi:10.1097/BOR.0b013e32834db4ee

    Article  CAS  PubMed  Google Scholar 

  3. Lu M, Bernatsky S, Ramsey-Goldman R, Petri M, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler EM, Yelin E, Bae SC, Wallace DJ, Jacobsen S, Dooley MA, Peschken CA, Alarcón GS, Nived O, Gottesman L, Criswell LA, Sturfelt G, Dreyer L, Lee JL, Clarke AE (2013) Non-lymphoma hematological malignancies in systemic lupus erythematosus. Oncology 85(4):235–40. doi:10.1159/000350165

    Article  CAS  PubMed  Google Scholar 

  4. Parikh AR, Olnes MJ, Barrett AJ (2012) Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab. Semin Hematol 49(4):304–11. doi:10.1053/j.seminhematol.2012.07.004

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Bussone G, Ribeiro E, Dechartres A, Viallard JF, Bonnotte B, Fain O, Godeau B, Michel M (2009) Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases. Am J Hematol 84(3):153–7. doi:10.1002/ajh.21341

    Article  CAS  PubMed  Google Scholar 

  6. Jonasova A, Neuwirtova R, Cermak J, Vozobulová V, Mociková K, Sisková M, Hochová I (1998) Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 100(2):304–9

    Article  CAS  PubMed  Google Scholar 

  7. Stadler M, Germing U, Kliche KO, Josten KM, Kuse R, Hofmann WK, Schrezenmeier H, Novotny J, Anders O, Eimermacher H, Verbeek W, Kreipe HH, Heimpel H, Aul C, Ganser A (2004) A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia 18(3):460–5

    Article  CAS  PubMed  Google Scholar 

  8. Sloand EM, Olnes MJ, Shenoy A, Weinstein B, Boss C, Loeliger K, Wu CO, More K, Barrett AJ, Scheinberg P, Young NS (2010) Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions. J Clin Oncol 28(35):5166–73. doi:10.1200/JCO.2010.29.7010

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Passweg JR, Giagounidis AA, Simcock M, Aul C, Dobbelstein C, Stadler M, Ossenkoppele G, Hofmann WK, Schilling K, Tichelli A, Ganser A (2011) Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care—SAKK 33/99. J Clin Oncol 29(3):303–9. doi:10.1200/JCO.2010.31.2686

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Immunology and Allergy, Department of Medical Specialties, School of Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211, Geneva 14, Switzerland

    Federico Simonetta, Magdalena Posa, Jean Villard & Carlo Chizzolini

  2. Hematology, Department of Medical Specialties, School of Medicine, Geneva University Hospitals, Geneva, Switzerland

    Federico Simonetta & Kaveh Samii

  3. U837, INSERM, Lille, France

    Alice Marceau-Renaut & Claude Preudhomme

  4. Hematology Laboratory, Biology and Pathology Center, Lille University Hospital, Lille, France

    Alice Marceau-Renaut & Claude Preudhomme

Authors
  1. Federico Simonetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magdalena Posa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean Villard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alice Marceau-Renaut
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claude Preudhomme
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kaveh Samii
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Carlo Chizzolini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Federico Simonetta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simonetta, F., Posa, M., Villard, J. et al. Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab. Ann Hematol 94, 1247–1249 (2015). https://doi.org/10.1007/s00277-015-2363-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2363-6

Keywords

Search

Navigation